Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of tumor-activated immuno-oncology therapies for the treatment of cancer. The firm uses its Geographically Precise Solutions (GPS) platform to develop tumor-activated molecules, including cytokines, antibodies and other biologics. The company was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
76
Frequently Asked Questions
What is Market Cap of Xilio Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Xilio Therapeutics Inc market cap is $54.84M.
What is the 52-week high for Xilio Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Xilio Therapeutics Inc 52 week high is $12.74 as of June 17, 2026.
What is the 52-week low for Xilio Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Xilio Therapeutics Inc 52 week low is $6.47 as of June 17, 2026.
What is Xilio Therapeutics Inc stock price today?
Xilio Therapeutics Inc stock price today is $8.25.
What was Xilio Therapeutics Inc stock price yesterday?
Xilio Therapeutics Inc stock price yesterday was $8.34.
What is the PE ratio of Xilio Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Xilio Therapeutics Inc's P/E ratio is -2.26.
What is the Price-to-Book ratio of Xilio Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Xilio Therapeutics Inc P/B ratio is 0.6576.
What is the 50-day moving average of Xilio Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Xilio Therapeutics Inc 50-day moving average is $8.22.
How many employees does Xilio Therapeutics Inc have?